Aptamer Discovery Services
Start with a target and build a selection plan around target presentation, specificity controls, enrichment, and candidate prioritization.
Creative Biolabs Services
Creative Biolabs brings aptamer discovery, engineering, characterization, and assay development into one research service framework. Start with your target, the stage of your program, and what you need the aptamer to do. We can help you choose a practical entry point without forcing every project through the same route.
Choose the service that matches the stage of your program. Existing discovery and characterization services can be entered directly. Engineering and assay-development needs can also be scoped as part of a broader aptamer program.
Start with a target and build a selection plan around target presentation, specificity controls, enrichment, and candidate prioritization.
Refine an existing aptamer for sequence format, chemical design, stability needs, or other downstream research constraints.
Measure candidate binding behavior and define the assays needed to compare affinity, specificity, or other agreed properties.
Translate a suitable aptamer into a research assay concept with a defined readout, sample context, and performance question.
Creative Biolabs starts with what you already have. A new target needs a different entry point from an enriched pool, a characterized sequence, or an aptamer that is ready for assay integration.
Begin with Aptamer Discovery Services and choose the selection route by target type and binding context.
Use Aptamer Characterization Services to compare candidate binding and specificity under the conditions that matter to the project.
Aptamer engineering and Aptamer Optimization Services can address sequence or format questions after the starting binder is defined.
Assay development begins with a suitable binder, a defined sample, and a measurable readout. The aptamer may need characterization or optimization first.
Aptamer development is not one fixed chain. Some projects stop after discovery. Others move through characterization, optimization, and assay work. The sequence depends on the research question and the evidence already available.
Clarify the target, intended binding context, specificity need, and downstream use before choosing a service route.
Use a target-appropriate selection strategy to enrich and prioritize sequences with the desired binding profile.
Compare binding, specificity, and other agreed properties before investing in later-stage engineering.
Adjust sequence length, chemistry, stability, or format only when the downstream use creates a clear need.
Translate a suitable aptamer into an assay or application format with defined sample and signal requirements.
| Research goal | Best starting point | Why this route | Next decision |
|---|---|---|---|
| Generate new binders for a target | Aptamer Discovery Services | Selection design is driven by target type, target presentation, and the specificity question. | Continue to Aptamer Discovery Services to choose the target-specific selection route. |
| Compare existing candidates | Aptamer Characterization Services | Candidate sequences already exist, so the key question is how to measure and compare binding behavior. | Define the binding and specificity assays that matter. |
| Improve a lead sequence | Aptamer Optimization Services | A known binder can be refined around an identified limitation or downstream format. | Define what needs to improve and how success will be checked. |
| Build an aptamer-based research assay | Aptamer Assay Development Services | The binder must be matched to sample type, signal format, and intended readout. | Confirm that the starting aptamer is sufficiently characterized for assay work. |
Exact inputs, assays, and deliverables are defined during project scoping. Not every aptamer program requires every service stage.
Technology choice sits inside the discovery stage. It should follow the target and selection problem rather than lead the project by default.
Compare specialized platforms and selection strategies when target presentation, partitioning, or control design changes the selection problem.
Consider this strategy when a small-molecule target is difficult or undesirable to immobilize directly.
Use negative-selection logic when known off-targets or background components must be actively depleted during discovery.
Biosensing, cell research, molecular imaging, delivery, and other research uses can change the desired aptamer format and validation plan.
Start with Aptamer Discovery Services. The first decision is usually how the target should be presented and what must be distinguished during selection.
No. The service path depends on what you already have and what decision comes next. A project can stop after any stage when the research goal has been met.
Yes. Existing candidates can enter characterization or optimization directly when the sequence and prior evidence are available for review.
The choice follows target presentation, partitioning needs, background, specificity controls, and the amount of sequence information needed during selection.
Target identity or sequence, available material, intended use, known off-targets, sample context, and any existing aptamer data are useful starting points.
Yes. We can scope adjacent characterization, optimization, or assay-development work when those steps are relevant to the research objective.
Tell Creative Biolabs what you have now and what decision you need to make next. We can help you choose a focused service path for your research program.